@lymepoet,

Spirochetes ... you've gotta hate them.

There's a lot of people working on it though. I've been in communication with Eva Sapi at the University of New Haven. They've had some luck killing off the L-Form of Borrelia Burgdorferi, which is a really vexing problem as they have no cell walls and therefore are immune to the actions of many antibiotics. A small clinical trial was underway when we communicated (a couple of months ago).

Earlier this year, McGill published a paper in which they describe a way of attacking biofilms that is reminiscent of the approach Katie and I have been working on for the past couple of years.

The problem is that for so long (since Louis Pasteur), medical science has focused upon "planktonic" bacteria (free-dwelling bacteria) and not on biofilms (living in colonies protected by a protective EPS matrix). The differences between the two: in their metabolism; DNA expression and body morphology - are stark. There's A LOT of catching up to do and, unfortunately, the world of medicine moves at a glacial place when it comes to paradigm-shifting.

Frustrating.

It is, however, changing. The amount of research into biofilms has increased significantly even in the past couple of years and the rate of increase is accelerating. What was once on the periphery is rapidly moving main stream.

It's tough, but hang in there.

Be careful, though, about what you read on the Internet ... there's a lot of well-intentioned baloney out there. There are Lyme sufferers spending a lot of money taking pills and extracts that cannot even survive passage through the digestive tract, let alone get absorbed into the blood stream (in meaningful amounts) or cross the blood brain barrier. Most of the botanicals work "because" they are chemically unstable. Curcumin is an excellent example (we've done a ton of experimentation with Curcumin). It's extremely useful, and hence the billions spent on it every year, but the existing products are all but useless.